Results of Sofosbuvir Plus Ribavirin in Patients With Hepatitis C Related Decompensated Cirrhosis

BACKGROUND: Sofosbuvir (SOF), a direct acting antiviral, has revolutionized the treatment of chronic Hepatitis C Virus (HCV) infection. However, data is scarce about efficacy of SOF plus Ribavarin (RBV) in Indian patients with decompensated cirrhosis. We evaluated the efficacy of SOF plus RBV in dec...

詳細記述

保存先:
書誌詳細
出版年:J Clin Exp Hepatol
主要な著者: Tmu, Naveen, Kumar, Ashish, Sharma, Praveen, Singla, Vikas, Bansal, Naresh, Arora, Anil
フォーマット: Artigo
言語:Inglês
出版事項: Elsevier 2019
主題:
Original Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363947/
https://ncbi.nlm.nih.gov/pubmed/30765933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2018.02.009
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料